Automated TNM staging aligned with AJCC guidelines, instant case summaries, pathology report analysis, and published treatment pathway integration that saves hours on every case.
Every oncologist faces these moments. We built Dashamlav because we lived them ourselves.
“Patient arrives with pathology, imaging, and lab reports spanning 15+ pages. You need T3N1M0 staging, biomarkers, and clinical synthesis extracted before they enter.”
Staging aligned with AJCC guidelines and all markers structured. Case summary instantly available. Walk in prepared.
“Department head needs a 6-month summary for review. Chemo, surgery, radiation… Where do you even start?”
One click generates a professional timeline. Alignment with guidelines and outcomes ready instantly.
“Searching PDFs at midnight for an updated guideline while your patient waits for a callback tomorrow.”
Input stage and histology. Relevant guidelines and treatment options appear instantly.
OncFlow is your AI-powered oncology intelligence layer—reviewed and validated by you—that works standalone or integrates with your existing EMR. From staging to summaries to guideline matching, everything ready for your clinical judgment in seconds.
AI-powered intelligence integrated throughout the OncFlow platform.
Upload complex pathology, imaging, and lab reports and get accurate, structured staging in seconds.
45 min manual work → 2 min AI extraction. Zero transcription errors.
Powered by OncFlow Engine
Compile complete patient timelines automatically with rationale aligned to guidelines.
2 hours of compilation → 2 minutes of generation. Professional and complete.
AI-powered Pathway Logic
Get the right published treatment pathway automatically—no PDF hunting.
Instant reference during patient discussions. Confidence in evidence-based care.
Integrated Guideline Matching
Desktop intelligence that extends to mobile—for both patients and physicians.
Access OncFlow intelligence on your phone. Review cases, check staging, view guidelines—anywhere, anytime.
Your patients track symptoms, view treatment schedules, and communicate side effects—all feeding back into OncFlow for your review.
Here’s what oncologists are experiencing daily with OncFlow
“OncFlow has helped us digitize and consolidate patient information on one single platform, improving decision making and overall efficiency across our department. Now I review 12 cases in an hour because OncFlow has already extracted staging, generated summaries, and pulled relevant published guidelines.”
“OncFlow has transformed how our hospital operates—not just in one department, but across the entire care continuum. The administrative burden on our clinical staff has dropped significantly. Everything we need is structured in one place: pathology reports, TNM staging, treatment timelines. Our doctors can walk into patient consultations fully prepared instead of hunting for information.”
“Dashamlav’s product suite has meaningfully improved our workflows, patient data management, and clinical decision-making. Several key capabilities were co-developed with our team, reflecting Dashamlav’s collaborative approach, speed, and agility in responding to real oncology needs.”
“The OncFlow ecosystem has been transformative—we now access real-time patient information and significantly increase treatment planning efficiency. I was skeptical of AI in oncology at first. OncFlow correctly staged complex cases and flagged cancerous invasions buried in pathology reports.”
AI validation runs throughout the entire platform
Every TNM calculation uses the current edition for that specific malignancy
Treatment pathways matched to patient stage automatically with current version tracking
Dr. Chufal and Dr. Miller personally validate all clinical logic and staging rules
Real scenarios from oncologists using OncFlow daily
Dr. Singh has tumor board at 10 AM. Eight new cases to present. He opens OncFlow at 8:30 AM and begins her preparation.
Opens first patient in OncFlow. TNM staging already extracted by the OncFlow from yesterday’s pathology report (T3N1M0). Case summary auto-generated showing diagnosis date, neoadjuvant chemo response, surgical pathology, current status. Published guideline recommendation for Stage IIIB colon cancer displayed. Ready to present. Seven more cases to go.
Reviews case #5, a complex rectal cancer. OncFlow’s imaging timeline shows response to neoadjuvant chemoradiation. Surgical pathology with pathologic complete response highlighted. Adjuvant treatment recommendation based on ypT0N0 stage clearly displayed.
All 8 cases prepped and organized in OncFlow. Has 15 minutes for coffee before tumor board. Previously this prep would take until 11:30 AM.
Presents cases confidently with all data at fingertips. Published guidelines displayed for team discussion. Consensus recommendations documented in real-time.
Dr. Patel gets a call. New consult for Stage III lung cancer. Patient wants to discuss treatment options tomorrow morning at 8 AM. He’s at home having dinner with family but needs to prepare.
Opens OncFlow on his home computer. Enters patient’s TNM stage (T2N2M0) and histology (adenocarcinoma). Adds EGFR and ALK status from molecular report.
OncFlow displays guideline-aligned treatment options: Concurrent chemoradiation (definitive treatment) or neoadjuvant chemotherapy followed by surgery. Each option shows evidence level and survival data from published guidelines.
Creates patient-friendly comparison sheet of both treatment approaches. Includes side effect profiles, treatment duration, expected outcomes. Formatted for patient discussion tomorrow. Patient will receive it via PulseDash after tomorrow’s consultation.
Done. Returns to family dinner. Tomorrow morning he’ll have an informed discussion with patient and family. If questions come up during his commute, he can review the case on MedCompass.
Dr. Chen is writing a paper on treatment outcomes for HER2-positive breast cancer patients. She needs data from her own practice for the past 5 years.
Traditional approach: Weeks of manual chart review, spreadsheet compilation, data cleaning, hoping she didn’t miss patients or make transcription errors.
Types in search: “HER2-positive breast cancer patients treated 2020-2024”
Specifies: Stage II-III, received neoadjuvant chemotherapy
47 patients matching criteria. Complete data displayed: staging, treatment regimens, pathologic response rates, recurrence status. All structured and validated—captured automatically during routine clinical care in OncFlow.
Adds filter: Received trastuzumab + pertuzumab regimen specifically. Cohort narrows to 32 patients.
Downloads to Excel with all variables properly coded: demographics, tumor characteristics, treatment details, toxicity grades (CTCAE), outcomes. Ready for statistical analysis.
What would have taken 5 weeks of chart review took 15 minutes with OncFlow. Data is research-grade quality because it was structured during clinical care, not retrospectively abstracted with errors.
See how OncFlow can transform your daily workflow. Schedule a personalized demo today.
Schedule Your Personal DemoMost oncologists are convinced within 10 minutes. See why 150+ clinicians trust OncFlow daily.